We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Study Extends Potential of Personalized Cell-based Immunotherapies

News   Mar 16, 2018 | Original story from Ludwig Institute for Cancer Research

 
Study Extends Potential of Personalized Cell-based Immunotherapies

Shown here is a pseudo-colored scanning electron micrograph of an oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red), part of a natural immune response. Credit: Rita Elena Serda, NCI/Duncan Comprehensive Cancer Center at Baylor College of Medicine

 
 
 

RELATED ARTICLES

Therapy Combo Promising in Small Cell Lung Cancer Model

News

A combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

READ MORE

100,000-person Study Investigates Association Between Antiepileptic Drugs and Dementia

News

A study has investigated the hypothetical association between antiepilipetic drug use and dementia risk in 101,150 individuals receiving treatment from more than 1,400 physicians in Germany.

READ MORE

Novel Binding Site for Anti-cancer Drugs

News

A research team at the Medical University of South Carolina (MUSC) has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE